Anteris Technologies Global Corp. (AVR)

Market Cap	201.15M
Revenue (ttm)	2.83M
Net Income (ttm)	-71.77M
Shares Out	21.14M
EPS (ttm)	-3.87
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,014
Open	5.70
Previous Close	5.78
Day's Range	5.55 - 5.75
52-Week Range	5.10 - 6.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AVR

Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaf...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 13, 2024
• Employees: 138
• Stock Exchange: NASDAQ
• Ticker Symbol: AVR
• Website: https://anteristech.com

Financial Performance

In 2023, AVR's revenue was $4.11 million, a decrease of -10.43% compared to the previous year's $4.59 million. Losses were -$67.33 million, 51.9% more than in 2022.

Financial numbers in USD